Your browser doesn't support javascript.
loading
Alectinib for the treatment of ALK-positive stage IV non-small cell lung cancer.
Wong, K M; Noonan, S; O'Bryant, C; Jimeno, A.
Affiliation
  • Wong KM; University of Colorado School of Medicine, Division of Medical Oncology, Aurora, Colorado, USA.
  • Noonan S; University of Colorado School of Medicine, Division of Medical Oncology, Aurora, Colorado, USA.
  • O'Bryant C; University of Colorado School of Medicine, Division of Medical Oncology, Aurora, Colorado, USA.
  • Jimeno A; University of Colorado School of Medicine, Division of Medical Oncology, Aurora, Colorado, USA. antonio.jimeno@ucdenver.edu.
Drugs Today (Barc) ; 51(3): 161-70, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25876560
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Carbazoles / Receptor Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2015 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Carbazoles / Receptor Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2015 Document type: Article Affiliation country: Country of publication: